Saturday, January 29, 2022

S Maghrabi

S Maghrabi
S Maghrabi joined My Healthy Click as a medical and public health news writer. She has years of experience in writing for online readers. She now leads and manages the editorial team of My Healthy Click. She supervises all strategy and content initiatives. She has more than 15 years of experience as a professional writer, editor, and content strategist. Off the office, she enjoys long walks along the beach, exercising, cooking, and spending time with her beloved pets.


A new study by the University of Calgary has shown that hydroxychloroquine is a promising drug candidate for slowing primary progressive multiple sclerosis (MS), a type of MS. Hydroxychloroquine is used to treat or prevent malaria. It is also used to treat rheumatoid arthritis and lupus.
The Food and Drug Administration (FDA) announced emergency approval of Pfizer’s Paxlovid (nirmatrelvir and ritonavir) for mild to moderate COVID infection. Médecins Sans Frontières (MSF), aka Doctors Without Borders, responded to the recent approval, highlighting a few limitations.
Chrissy Teigen has recently explained why she had to undergo an eyebrow transplant, revealing the outcome of the procedure. She said she went through the procedure because she used to overpluck her eyebrows in her teens. She said she now has dark eyebrows due to the procedure.
A new experimental compound has shown promise in reducing uncontrolled, erratic muscle movements, called dyskinesia, associated with Parkinson’s disease. In animal studies, the compound reduced dyskinesia by 85%, a common side effect of levodopa used in Parkinson’s patients.
The FDA approved the use of InVisionOS, a virtual reality (VR) surgical planning tool, in November, which will be available early next year. The tool, developed by Canadian-based PrecisionOS, allows surgeons to plan operations using VR.

Recent Posts